<DOC>
	<DOCNO>NCT00004422</DOCNO>
	<brief_summary>OBJECTIVES : Assess efficacy single infusion high titer pertussis immune globulin treatment severe pertussis child .</brief_summary>
	<brief_title>Intravenous Pertussis Immune Globulin Patients With Severe Childhood Pertussis Infection</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , multicenter study . Patients randomize receive infusion either pertussis immune globulin placebo ( 0.9 % saline ) . Patients follow every 2 week 6 month . Completion date provide represent completion date grant per OOPD record</detailed_description>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>Rho ( D ) Immune Globulin</mesh_term>
	<criteria>Documented infection Bordetella pertussis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>June 2000</verification_date>
	<keyword>bacterial infection</keyword>
	<keyword>immunologic disorder infectious disorder</keyword>
	<keyword>pertussis</keyword>
	<keyword>rare disease</keyword>
</DOC>